Stay updated on Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial
Sign up to get notified when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.

Latest updates to the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe Publications section now states that publications are automatically filled from PubMed, with a new revision tag v3.3.2. The previous PubMed-origin wording based on an NCT Number identifier (v3.2.0) was removed.SummaryDifference0.1%

- Check20 days agoChange DetectedThe page no longer displays the government funding notice banner about operating status and data recency. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedThe new page retains the same study details (title, conditions, eligibility criteria, outcomes, and locations) as the previous version; only layout and styling appear to be updated. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check63 days agoChange DetectedMajor update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.SummaryDifference5%

- Check70 days agoChange DetectedRemoved several MedlinePlus topics and updated to revision v3.1.0. The page now reflects a newer version while omitting topics on drug safety and quality that were previously listed.SummaryDifference0.7%

- Check84 days agoChange DetectedPage revision updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.3%

Stay in the know with updates to Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Oral Oteseconazole for Recurrent Vaginal Candidiasis Clinical Trial page.